T1	Pharmacodynamic_phenotype	0 38	The efficacy of icotinib hydrochloride
T2	Phenotype	59 84	ECOG performance status ,
T3	Phenotype	85 102	smoking history ,
T4	Limited_variation	103 120	EGFR mutation and
T5	Phenotype	121 139	rash significantly
R1	isAssociatedWith	Arg1:T1	Arg2:T2
R2	isAssociatedWith	Arg1:T1	Arg2:T3
R3	isAssociatedWith	Arg1:T1	Arg2:T4
R4	isAssociatedWith	Arg1:T1	Arg2:T5
R5	influences	Arg1:T2	Arg2:T1
R6	isAssociatedWith	Arg1:T2	Arg2:T3
R7	isAssociatedWith	Arg1:T2	Arg2:T4
R8	isAssociatedWith	Arg1:T2	Arg2:T5
R9	isAssociatedWith	Arg1:T3	Arg2:T2
R10	isAssociatedWith	Arg1:T3	Arg2:T4
R11	isAssociatedWith	Arg1:T3	Arg2:T5
R12	isAssociatedWith	Arg1:T4	Arg2:T1
R13	isAssociatedWith	Arg1:T4	Arg2:T2
R14	isAssociatedWith	Arg1:T4	Arg2:T3
R15	isAssociatedWith	Arg1:T4	Arg2:T5
R16	isAssociatedWith	Arg1:T5	Arg2:T1
R17	isAssociatedWith	Arg1:T5	Arg2:T2
R18	isAssociatedWith	Arg1:T5	Arg2:T3
R19	isAssociatedWith	Arg1:T5	Arg2:T4
